-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EeP/xS/sFTqQgdW/7IO/Jz6dvJjTA0Ko7rOQUVPl/97ghCiDV0QZLFw+ykuoFFLp 1o+rQJldxTha7yj/YVccPA== /in/edgar/work/0000950170-00-001676/0000950170-00-001676.txt : 20001027 0000950170-00-001676.hdr.sgml : 20001027 ACCESSION NUMBER: 0000950170-00-001676 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20001026 GROUP MEMBERS: FROST PHILLIP MD ET AL GROUP MEMBERS: FROST-NEVADA CORPORATION GROUP MEMBERS: FROST-NEVADA, LIMITED PARTNERSHIP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CONTINUCARE CORP CENTRAL INDEX KEY: 0000803352 STANDARD INDUSTRIAL CLASSIFICATION: [8082 ] IRS NUMBER: 592716063 STATE OF INCORPORATION: FL FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-46829 FILM NUMBER: 746710 BUSINESS ADDRESS: STREET 1: 100 SOUTHEAST 2ND ST STREET 2: 36TH FLOOR CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 3053507515 FORMER COMPANY: FORMER CONFORMED NAME: ZANART ENTERTAINMENT INC DATE OF NAME CHANGE: 19950420 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FROST PHILLIP MD ET AL CENTRAL INDEX KEY: 0000898860 STANDARD INDUSTRIAL CLASSIFICATION: [ ] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33137-3227 BUSINESS PHONE: 3055756001 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33137-3227 SC 13D/A 1 0001.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* CONTINUCARE CORPORATION ----------------------- (Name of Issuer) Common Stock, $.0001 par value --------------------------------------------- (Title of Class of Securities) 212172100 ---------------------------- (Cusip Number) Richard C. Pfenniger, Jr., 4400 Biscayne Boulevard, Miami, FL 33137 (305) 575-6000 ------------------------------------------------------------------------------ (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 25, 2000 --------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of the Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d- 1(f) or 13d-1(g), check the following box [ ]. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) - ------------------------------- ------------------------------- CUSIP No. 212172100 SCHEDULE 13D Page 2 of 7 Pages - ------------------------------- ------------------------------- - ------- ---------------------------------------------------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) PHILLIP FROST, M.D. - ------- ---------------------------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - ------- ---------------------------------------------------------------------------------------------------------------------------- 4 SOURCE OF FUNDS PF - ------- ---------------------------------------------------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION USA - ----------------------------------- ------ ----------------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 0 BENEFICIALLY ------ ----------------------------------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 5,646,733 REPORTING ------ ----------------------------------------------------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 ------ ----------------------------------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 5,646,733 - ------- ---------------------------------------------------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,646,733 - ------- ---------------------------------------------------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES * [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.9% - ------- ---------------------------------------------------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN - ------- ----------------------------------------------------------------------------------------------------------------------------
- ------------------------------- ------------------------------- CUSIP No. 212172100 SCHEDULE 13D Page 3 of 7 Pages - ------------------------------- ------------------------------- - ------- ---------------------------------------------------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) FROST-NEVADA, LIMITED PARTNERSHIP IRS I.D. #59-2749083 - ------- ---------------------------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - ------- ---------------------------------------------------------------------------------------------------------------------------- 4 SOURCE OF FUNDS OO - ------- ---------------------------------------------------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION NEVADA - ----------------------------------- ------ ----------------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 0 BENEFICIALLY ------ ----------------------------------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 5,646,733 REPORTING ------ ----------------------------------------------------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 ------ ----------------------------------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 5,646,733 - ------- ---------------------------------------------------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,646,733 - ------- ---------------------------------------------------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES * [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.9% - ------- ---------------------------------------------------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN - ------- ----------------------------------------------------------------------------------------------------------------------------
- ------------------------------- ------------------------------- CUSIP No. 212172100 SCHEDULE 13D Page 4 of 7 Pages - ------------------------------- ------------------------------- - ------- ---------------------------------------------------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) FROST-NEVADA CORPORATION IRS I.D. #59-2749057 - ------- ---------------------------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X] (b) [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - ------- ---------------------------------------------------------------------------------------------------------------------------- 4 SOURCE OF FUNDS OO - ------- ---------------------------------------------------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION NEVADA - ----------------------------------- ------ ----------------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 0 BENEFICIALLY ------ ----------------------------------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 5,646,733 REPORTING ------ ----------------------------------------------------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 ------ ----------------------------------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 5,646,733 - ------- ---------------------------------------------------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,646,733 - ------- ---------------------------------------------------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES * [ ] - ------- ---------------------------------------------------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.9% - ------- ---------------------------------------------------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON CO - ------- ----------------------------------------------------------------------------------------------------------------------------
Item 1. Security and Issuer. This is Amendment No. 6 to the original Schedule 13D previously filed by Phillip Frost, M.D., Frost-Nevada, Limited Partnership (the "Partnership"), and Frost-Nevada Corporation (collectively, the "Reporting Persons") with respect to the Common Stock, $.0001 par value (the "Shares") of Continucare Corporation (f/k/a Zanart Entertainment Incorporated) (the "Issuer"). The principal executive offices of the Issuer are located at 80 Southwest 8th Street, Suite 2350, Miami, Florida, 33131. Item 3. Source and Amount of Funds or Other Consideration. Item 3 is amended and supplemented as follows: The aggregate purchase price of the 448,100 Shares of the Issuer purchased by Phillip Frost, M.D. reported in this Amendment No. 6, was $336,411.95. The source of funds used by Dr. Frost in making these purchases were personal funds of Dr. Frost. No portion of the consideration used by Dr. Frost in making the purchases described above was borrowed or otherwise obtained for the purpose of acquiring, holding, trading or voting the Shares. Item 5. Interest in Securities of the Issuer. Item 5 is amended in its entirety and restated as follows: Amount of Shares Percentage Name Beneficially Owned of Class* ---- ------------------ ----------- Phillip Frost, M.D. 5,646,733** 16.9% Frost-Nevada Corporation 5,646,733** 16.9% Frost-Nevada, Limited 5,646,733** 16.9% Partnership - ---------------------------- * Based on 33,440,090 Shares outstanding at September 20, 2000 consisting of (i) 33,240,090 Shares outstanding as reported on the Issuer's Annual Report on Form 10-K for the year ended June 30, 2000, and (ii) assuming the conversion by Dr. Frost of stock options to purchase 200,000 Shares exercisable in the next sixty days. ** These Shares are owned of record by one or more of such Reporting Persons. As the sole limited partner of the Partnership and the sole shareholder of Frost-Nevada Corporation, the general partner of the Partnership, Dr. Frost may be deemed a beneficial owner of the Shares. Record ownership of the Shares may be transferred from time to time among any or all of Dr. Frost, the Partnership and Frost-Nevada Corporation. Accordingly, solely for purposes of reporting beneficial ownership of the Shares pursuant to Page 5 of 7 Section 13(d) under the Securities Exchange Act of 1934, as amended, each of Dr. Frost, the Partnership and Frost-Nevada Corporation will be deemed to be the beneficial owner of Shares held by any of them. Except as described herein, none of the Reporting Persons has engaged in any transaction involving Shares of the Issuer during the past sixty days. Item 6. Contents, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. On July 20, 2000 the Issuer granted to Dr. Frost [non qualified] stock options to purchase 100,000 Shares at a price of $0.69 per Share (the "2000 Options"). The options are immediately exercisable and expire on July 20, 2010. The options were granted to Dr. Frost in connection with his service as a director of the Issuer. The foregoing description of the 2000 Options is qualified in its entirety by the text of the Non Qualified Stock Option Agreement dated July 20, 2000 between the Issuer and Dr. Frost which is filed as an exhibit hereto and incorporated by reference herein. Item 7. Material to be Filed as Exhibits. 1. Joint Filing Agreement. 2. Description of Transactions in the Issuer's Shares by Phillip Frost, M.D. 3. Third Amended and Restated Agreement of Frost-Nevada, Limited Partnership, Frost-Nevada Corporation and Phillip Frost, M.D. filed pursuant to Rule 13d-l(f)(l)(iii) of the Securities and Exchange Commission (previously filed). 4. Non-Qualified Stock Option Agreement dated July 31, 1997, between the Issuer and Phillip Frost, M.D. (previously filed). 5. Non-Qualified Stock Option Agreement, dated July 20, 2000 between the Issuer and Phillip Frost, M.D. Page 6 of 7 SIGNATURES After reasonable inquiry and to the best of the undersigned's knowledge and belief, the undersigned certify that the information set forth in this Amendment is true, complete and correct. /s/Phillip Frost, M.D. ----------------------------------------- Date: October 26, 2000 Phillip Frost, M.D. FROST-NEVADA, LIMITED PARTNERSHIP /s/David H. Moskowitz ----------------------------------------- Date: October 26, 2000 David H. Moskowitz President of Frost-Nevada Corporation, General Partner FROST-NEVADA CORPORATION /s/David H. Moskowitz ----------------------------------------- Date: October 26, 2000 David H. Moskowitz President Page 7 of 7 EXHIBIT INDEX Exhibit Description - ------- ----------- 1 Joint Filing Agreement 2 Description of Transactions in the Issuer's Shares by Phillip Frost, M.D. 5. Non-Qualified Stock Option Agreement, dated July 20, 2000 between the Issuer and Phillip Frost, M.D. EX-1 2 0002.txt EXHIBIT 1 The undersigned hereby agree that this Amendment to the Schedule 13D filed by us with respect to the Common Stock of Continucare Corporation is filed on behalf of each of us. /s/Phillip Frost, M.D. ----------------------------------------- Date: October 26, 2000 Phillip Frost, M.D. FROST-NEVADA, LIMITED PARTNERSHIP /s/David H. Moskowitz ----------------------------------------- Date: October 26, 2000 David H. Moskowitz President of Frost-Nevada Corporation, General Partner FROST-NEVADA CORPORATION /s/David H. Moskowitz ----------------------------------------- Date: October 26, 2000 David H. Moskowitz President EX-2 3 0003.txt EXHIBIT 2 Set forth below is a summary of acquisitions and dispositions of beneficial ownership in the Shares of the Issuer by the Reporting Persons effected in the sixty days preceding the date of this Amendment No. 6. Number of Shares Price Per Type Of Date Acquired Share Transaction ---- -------- ----- ----------- 6/19/00 240,000 $ .75 Open Market Transaction 6/20/00 20,700 $ .73 Open Market Transaction 8/25/00 80,800 $ .75 Private Purchase 9/15/00 8,100 $ .6875 Open Market Transaction 9/15/00 49,500 $ .75 Open Market Transaction 10/16/00 32,000 $ .625 Open Market Transaction 10/17/00 10,000 $ .625 Open Market Transaction 10/17/00 7,000 $ .5786 Open Market Transaction 10/20/00 7,000 $ .625 Open Market Transaction 10/23/00 4,000 $ .625 Open Market Transaction 10/24/00 600 $ .625 Open Market Transaction EX-5 4 0004.txt EXHIBIT 5 CONTINUCARE CORPORATION AMENDED AND RESTATED 1995 STOCK OPTION PLAN -------------------------------------- STOCK OPTION AGREEMENT (a) Grant of Option. As of the 20th of July, 2000, Continucare Corporation, a Florida corporation (the "Company"), hereby grants to Phillip Frost, M.D. (the "Optionee") a non-qualified stock option (the "Option") to acquire One Hundred thousand (100,000) shares of Common Stock, $0.0001 par value per share (the "Shares"), of the Company pursuant to the Company's Amended and Restated 1995 Stock Option Plan (the "Plan"), which is incorporated herein for all purposes. The Optionee hereby acknowledges receipt of the Plan and agrees to be bound by all of the terms and conditions herein and therein. (b) Definitions. Capitalized terms used herein without definition shall have the meanings as set forth in the Plan. (c) Exercise Price. The exercise price per share of the Shares subject to this Option is $0.69. (d) Exercise Schedule. The Options shall vest as follows: 100% immediately, except as otherwise provided for in Section 9 of the Plan. (e) Termination of Option. This Option shall terminate, and in no event be exercisable, after the expiration of 10 years from the date on which the Option is granted. In addition, any unexercised portion of this Option shall automatically and without notice terminate and become null and void as provided in Section 10 of the Plan. (f) Section 83(b) Election. If as a result of exercising all or any part of this Option, an Optionee receives Shares that are subject to a "substantial risk of forfeiture" and are not "transferable" as those terms are defined for purposes of Section 83(a) of the Internal Revenue Code of 1986, as amended (the "Code"), then such Optionee may elect under Section 83(b) of the Code to include in the Optionee's gross income, for the Optionee's taxable year in which the Shares are transferred to the Optionee, the excess of the Fair Market Value of such Shares at the time of transfer (determined without regard to any restriction other than one that by its terms will never lapse), over the amount paid for the Shares. If the Optionee makes the Section 83(b) election described above, the Optionee shall (i) make such election in a manner that the Board determines in its reasonable judgment to be satisfactory, (ii) provide the Company with a copy of such election, (iii) agree to promptly notify the Company if any Internal Revenue Service or state tax agent, on audit or otherwise, questions the validity or correctness of such election or of the amount of income reportable on account of such election, and (iv) agree to such tax withholding as the Board may reasonably require in its sole and absolute discretion. (g)7. Law Governing. This Agreement shall be governed in accordance with the internal laws of the State of Florida. 8. Interpretation. The Optionee accepts this Option subject to all the terms and provisions of the Plan and this Agreement. The undersigned Optionee hereby accepts as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under the Plan and this Agreement. 9. Notices. Any notice under this Agreement shall be in writing and shall be deemed to have been duly given when delivered personally or when deposited in the United States mail, registered, postage prepaid, and addressed, in the case of the Company, to the Company's Secretary at 80 SW 8/th/ Street, Miami, FL 33130, or if the Company should move its principal office, to such principal office, and, in the case of the Optionee, to the Optionee's last permanent address as shown on the Company's records, subject to the right of either party to designate some other address at any time hereafter in a notice satisfying the requirements of this Section. COMPANY: ------- CONTINUCARE CORPORATION By: --------------------------------- Spencer J. Angel President and Chief Executive Officer OPTIONEE: -------- ------------------------------------ Phillip Frost, M.D. -----END PRIVACY-ENHANCED MESSAGE-----